TerminatedNot Applicable

A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy

Stopped: Terminated by IRB

United States54 participantsStarted 2006-05-25

Plain-language summary

The purpose of this trial is to determine whether a mucosa-to-mucosa technique of pancreaticojejunostomy will improve the pancreatic fistula rate.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients must have undergone pancreaticoduodenectomy. * Must have pancreatic remnant remaining in place (body and tail). * Must be candidate for reconstruction by pancreaticojejunostomy by one of the two techniques described below. * Must have an identifiable pancreatic duct which can be used for a duct-to-mucosa anastomosis. Exclusion Criteria: * Patients undergoing total pancreatectomy. * Patients undergoing PD who have had previous left-sided pancreatic resection. * Failure to sign informed consent. * Failure to identify the pancreatic duct. * Pregnant patients.

What they're measuring

The primary endpoint will be the pancreatic fistula rate.

Timeframe: 1 year

Trial details

NCT IDNCT00359320

SponsorThomas Jefferson University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-07-12

View on ClinicalTrials.gov More Pancreatic Neoplasms trials